October 20, 2016 8:29 PM ET


Company Overview of Pearl Therapeutics Inc.

Executive Profile

Charles J. Bramlage MBA

Chief Executive Officer, President and Director, Pearl Therapeutics Inc.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 4 different industries.

See Board Relationships


Mr. Charles J. Bramlage, also known as Chuck, MBA, has been the Chief Executive Officer and President of Pearl Therapeutics, Inc. since February 24, 2011. Mr. Bramlage serves as President of Pharmaceutical Products at Mallinckrodt, Inc. He served as President of Pharmaceutical Products at Covidien plc. since May 29, 2008. He served as President of European Operations at Valeant Pharmaceuticals International (Formerly ICN Pharmaceuticals Inc.) from September 3, 2003 to ...

Corporate Headquarters

200 Cardinal Way
Redwood City, California 94063

United States

Phone: 650-305-2600
Fax: 650-568-1804

Board Members Memberships

Chief Executive Officer, President and Director
Independent Director, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee


The Ohio State University
University of Dayton

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Pearl Therapeutics Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.